Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W R Fair

Showing results (61-70 of 290) with videos related to

Pageof 29
Sort By:
Molecular Urology|November 4, 2000
Update on Memorial Sloan-Kettering Cancer Center studies of neoadjuvant hormonal therapy for prostate cancerW R Fair, J E Betancourt
Journal of Surgical Oncology|January 1, 1994
Technique for the management of Santorini's deep venous plexus during radical retropubic prostatectomyB E Davis, W R Fair
The Journal of Urology|December 1, 1974
Comparison of split function ratios with renal vein renin ratios in patients with curable hypertension caused by unilateral renal artery stenosisA J Schaeffer, W R Fair
Surgical Oncology Clinics of North America|October 6, 1997
Neoadjuvant hormonal therapy plus surgery for prostate cancer. The MSKCC experienceW R Fair, H I Scher
The Journal of Urology|December 1, 1978
The pH of prostatic fluid: a reappraisal and therapeutic implicationsW R Fair, J J Cordonnier
Progress in Clinical and Biological Research|January 1, 1981
Antibacterial substances in prostatic fluidW R Fair, R F Parrish
Journal of Cellular Biochemistry. Supplement|January 1, 1992
Neoadjuvant hormonal manipulation: a strategy for chemoprevention trialsW R Fair, A Aprikian, V Reuter
Biochemical Medicine|October 1, 1973
The purification and assay of the prostatic antibacterial factor (PAF)W R Fair, J Couch, N Wehner
Urology|February 1, 1976
Prostatic antibacterial factor. Identity and significanceW R Fair, J Couch, N Wehner
The Journal of Urology|October 23, 1998
Site specific predictors of positive margins at radical prostatectomy: an argument for risk based modification of techniqueF Rabbani, A Bastar, W R Fair
Pageof 29

Showing results (61-70 of 290) with videos related to

Sort By:
Pageof 29
Molecular Urology|November 4, 2000
Update on Memorial Sloan-Kettering Cancer Center studies of neoadjuvant hormonal therapy for prostate cancerW R Fair, J E Betancourt
Journal of Surgical Oncology|January 1, 1994
Technique for the management of Santorini's deep venous plexus during radical retropubic prostatectomyB E Davis, W R Fair
The Journal of Urology|December 1, 1974
Comparison of split function ratios with renal vein renin ratios in patients with curable hypertension caused by unilateral renal artery stenosisA J Schaeffer, W R Fair
Surgical Oncology Clinics of North America|October 6, 1997
Neoadjuvant hormonal therapy plus surgery for prostate cancer. The MSKCC experienceW R Fair, H I Scher
The Journal of Urology|December 1, 1978
The pH of prostatic fluid: a reappraisal and therapeutic implicationsW R Fair, J J Cordonnier
Progress in Clinical and Biological Research|January 1, 1981
Antibacterial substances in prostatic fluidW R Fair, R F Parrish
Journal of Cellular Biochemistry. Supplement|January 1, 1992
Neoadjuvant hormonal manipulation: a strategy for chemoprevention trialsW R Fair, A Aprikian, V Reuter
Biochemical Medicine|October 1, 1973
The purification and assay of the prostatic antibacterial factor (PAF)W R Fair, J Couch, N Wehner
Urology|February 1, 1976
Prostatic antibacterial factor. Identity and significanceW R Fair, J Couch, N Wehner
The Journal of Urology|October 23, 1998
Site specific predictors of positive margins at radical prostatectomy: an argument for risk based modification of techniqueF Rabbani, A Bastar, W R Fair
Pageof 29